Clinical Trial of High Dose CoQ10 in ALS
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Hiroshi Mitsumoto
Wesley J. Howe Professor of Neurology at the New York Presbyterian Hospital/Columbia University Medical Center
Principal Investigator - J. L. P. Thompson, Ph.D.
Director, Statistical Analysis Center, Department of Biostatistics, Mailman School of Public Health (Statistical Principal Investigator)
Principal Investigator - Petra Kaufmann, MD
Assistant Professor, Division of Neuromuscular Disease, Columbia University Medical Center (Clinical Principal Investigator)
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
19 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- University of Arkansas for Medical Sciences, Department of Neurology
Little Rock, Arkansas, United States
- California Pacific Medical Center
San Francisco, California, United States
- University of California at San Francisco
San Francisco, California, United States
- University of Colorado Health Sciences, Dept of Neurology
Denver, Colorado, United States
- Yale University School of Medicine, Department of Neurology
New Haven, Connecticut, United States
- Northwestern University, Department of Neurology,
Chicago, Illinois, United States
- University of Chicago, Department of Neurology
Chicago, Illinois, United States
- University of Kansas Medical Center
Kansas City, Kansas, United States
- University of Kentucky, Dept of Neurology, College of Medicine
Lexington, Kentucky, United States
- Brigham and Women'S Hospital , Department of Neurology
Boston, Massachusetts, United States
- Baystate Medical Center, Division of Critical Care Research
Springfield, Massachusetts, United States
- Minneapolis Medical Research Foundation, ,
Minneapolis, Minnesota, United States
- Washington University in St. Louis School of Medicine, Department of Neurology
St Louis, Missouri, United States
- Columbia Presbyterian Medical Center, the Neurological Institute
New York, New York, United States
- State University of New York Upstate Medical, Neurology Department
Syracuse, New York, United States
- Cleveland Clinic Foundation
Cleveland, Ohio, United States
- Drexel University, Dept of Neurology
Philadelphia, Pennsylvania, United States
- University of Texas, Health Science Center at San Antonio, Division of Neurology
San Antonio, Texas, United States
- University of Vermont, Neurology Department
Burlington, Vermont, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Apr 2005
- Primary completion
- 31 Mar 2008
- Completion
- 31 Mar 2008
- Last update posted
- 7 May 2024
- Registered enrollment
- 185
- Registry id
- NCT00243932
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.